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A P (mmHg) v (cm/s) FFR CVR SRv(mmHg/cm/s) 
h-x/ 35.6 f 16.6 30.3 * 18.5 0.62 * 0.17 1.66 f 0.54 2.05 zt 2.17 
&?/loon 16.1 * 9.07 44.6 * 11.2t 0.60~O.lOt 2.14 * 0.36’ 0.46 * 0.3lt 
Stenf 11.2 * 7.9 59.1 f 19.0* 0.88 * 0.09 2.88 * 0.62t 0.22 f 0.19 
UPstent 11.2 * 3.3 61.6 f 20.3 0.6a*o.l1 2.76 * 0.40 0.21 r 0.25 
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Background: FFR is a well-established hemodynamic parameter for physiological 
assessment of the severity of a single coronary lesion. We compared a novel algorithm 
to assess the individual FFR of each lesion in a vessel with serial lesions to the current 
method which requires multiple hyperemic injections and wedge pressure measure- 
ments. 
Methods: 26 patients undergoing intervention for two (n=24) or three (n=2) tandem 
lesions were studied. Basal and hyperemic pressure curves were measured distal to 
each of the serial stenoses. At least one lesion was treated in each patient based on 
angiographic evaluation. Wedge pressure was measured during balloon inflation for 
treatment of one of the lesions and used lo calculate the wedge based value of FFR 
(FFRwedge). FFRsmarlflow was derived from rest pressure across each of the serial 
lesions and one hyperemic pressure across all lesions. 
Results: Individual FFR obtained by both methods were highly correlated (wO.96, 
p<O.OOl). The correlation was significant for both the proximal lesion (r=0.93, pcO.001) 
and for the distal lesion (r= 0.99, pcO.001). Combining the proximal and distal lesions, 
there was no significant difference between the two methods (p= 0.733). 
Conclusions: FFRsmartflow allows real-time and accurate evaluation of lesion specific 
FFR in vessels with multiple serial lwons with only baseline pressure measurements 
between lesions and one distal measurement with adenosine injection. 
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Background: A recent study in the porcine coronary model demonstrated that 173 
sstradiol-eluting atents reduce neointimal formation by 40%. Whether 17-p estradiol has 
a similar vasculoprotective effect in the clinical setting is not known. 
Objective: To determine the safety of 17-p estradiol-eluting PC-coated stent (Bidi- 
vysioTM) in the treatment of de nova native coronary stenosis.: and the efficacy of this 
strategy on B-month binary restenosis and late loss as assessed by angiography. 
Methods: Thirty patients were studied in this prospective pilot registry. All pawn& 
received a single 15 or 16 mm drug-eluting Bidivysio TM stent. The average drug concen- 
tration was approximately 2.54p@mm’ as previously studied in the animal model. 
Results: Mean age was 61+12 years, 70% were men, 10% diabetics, 27% had hyperc- 
holesterolemia, and 44% previous MI. Lesion length was 9.1+2.4mm, and reference yes- 
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Post intervention In-stent In-segment 
. MLD (mm) 2.44 * 0.52 2.04 f 0.43 
. Diameter stenosis (%) 13.6 * 10.4 23.4 * 10.9 
Follow-up 
1149-196 The Importance of Combined Pressure and Flow 
Velocity Measurements to Evaluate the Hemodynamic 
Effect of Percutaneous Coronary Interventions 
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Academic Medical Center, Amsterdam, The Netherlands 
. MLD (mm) 1.69 * 0.57 1.76 zt 0.56 
_ Diameter stenosis (%) 28.2 * 14.6 30.5 + 14.9 
_ Late loss (mm) 0.54 + 0.44 0.31 * 0.38 
Binary restenosis occurred in 2 pts (6.6%) and ischemic driven target vessel revascular- 
izatlon in one (3.3%) with no additional major adverse cardiac events 
Conclusion: The implantafion of 17-p estradiol-eluting BiodlvysioTM stent was safe and 
associated with low binary restenosis and clinical recurrence. These data suppod the 
antiproliferative properties of estrogen and warrant further investigation in a larger ran- 
domized trial. 
Background: We simultaneously assessed distal flow velocity (v) and pressure with a 
novel 0.014” dual-sensor guide wire to determine the magnitude and sequence of hemo- 
dynamic changes that contribute to the outcome of percutaneous coronary intervention 
(PCI). 
Methods: Aortic pressure, Y, and distal pressure were measured after an i.c. bolus of 
adenosine in 12 patients with a single de nova lesion (56.4 * 12.5% diameter stenosis) 
before and after stepwise executed PCI (balloon angioplasiy, stenting and upsized stew 
ing guided by intravascular ultrasound). Pressure gradient (AP = aortic-distal pressure) 
and vat maximal hyperemia were compared per intervention step, as well as descriptors 
of functional stenosis severity, i.e., fractional (FFR) and coronary (CVR) flow reserve. 
and hyperemic stenosis resistance index (SRv=AP/v). 
Results: An initial large decrease inAP was followed by non-significant changes. In con- 
trast, v continued to increase significantly after the initial step. Upsized stenting caused 
variable results and slightly reduced CVR. Pressure-based parameters were least sensi- 
tive after the initial dilation, while SRv combined the sensitivity of AP and Y for all steps of 
PCI-induced hemodynamic changes. 
Conclusion: Stepwise executed PCI affects AP and v to variable degrees, with changes 
in pressure-based variables diminishing quickly. Assessment of PCI in hemodynamic 
terms benefits from combining pressure and velocity information and SRv may thus pro- 
vide a valuable prognostic tool. 
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Introduction: In vitro and animal models indicate that lip-&radio1 inhibits intimal smooth 
muscle cell proliferation and migration and accelerates re-endothelization after PTCA. 
This study prospectively and randomly compares stents loaded with lip-&radio1 (Biodi- 
vYsio DD Matrix, Biocompatibles, Galway, Ireland) to bare metal stents (BiodwYsio OC) 
in reducing restenosis rate. Methods we repolt the in-hospital and l-month follow-up 
(FU) results of the 2 different type of stents in de nova lwons located on native coronary 
arteries. In the study 61 patients with 111 lesions 54 (46%) in the estrogen arm and 57 
(52%) in the control arm. Complex lesions (82, C type ACClAHA) were 42% and 44% in 
the estrogen and in the control arm respectively (p=n.s.). No statistically significant differ- 
ences were noted between the 2 groups in baseline angiographic measurements (basal 
ref. diam. 2.69r 0.60 mm vs 2.95* 0.57 mm; MLD 0.97i 0.61 mm vs 1.02~ 0.56 mm: 
lesion length 11.7* 6.5 mm vs 13.9+ 9.6 mm I” the estrogen and in the control group 
respectively). nor after stenting (Final MLD 0.97+ 0.61 mm vs 1.02* 0.56 mm m the 
estrogen and in the control group respectively). After discharge, all patients have been 
